Chemokine CXCL1 in serum mediates the antinociceptive effect of manual acupuncture at ST36

Abstract

Background:

Inflammatory pain is the most common type of pain encountered clinically. The analgesic effect of acupuncture has been well-documented.

Objective:

The aim of this study was to investigate the involvement of chemokine CXCL1 in the serum on manual acupuncture (MA)-induced antinociception.

Methods:

Rats with inflammatory pain of the right hind paw were induced by intraplantar (i.pl.) administration of complete Freund’s adjuvant (CFA). After wards, the CFA-injected rats were treated daily with MA at ST36 from Day 1 to Day 7, and thermal nociceptive thresholds (paw withdrawal latency; PWL) were analyzed. The concentration of CXCL1 in the serum of the rats was measured by enzyme-linked immunosorbent assay (ELISA) after the first and the last MA treatment. Subsequently, the rats were injected with two doses (5 or 10 μg) of recombinant CXCL1 through the tail vein daily from Day 1 to Day 7 or injected with two doses (6.4 or 16 μg) of anti-CXCL1 antibody using the same methods and course at 30 min before MA, and the PWLs were measured again. Finally, naloxone (500 μg, 0.1 mL) was administered by i.pl. injection into the inflamed paw 5 min before the last MA treatment or last injection of recombinant CXCL1.

Results:

MA significantly increased the PWLs and upregulated the expression of serum CXCL1 in the CFA-injected rats. Without acupuncture, repeated tail vein injection of recombinant CXCL1 showed an analgesic effect on CFA-induced inflammatory pain. Conversely, the neutralization of serum CXCL1 by anti-CXCL1 antibody decreased MA-induced antinociception in a time-dependent manner. Anti-CXCL1 antibody injected just once before the first MA did not affect MA-induced antinociception. The analgesic effects of MA and recombinant CXCL1 were reversed by an i.pl. injection of naloxone.

Conclusion:

This study indicates MA at ST36 had an analgesic effect on inflammatory pain and found a novel function of CXCL1. Increased serum CXCL1 had an antinociceptive effect on inflammatory pain induced by CFA. CXCL1 in serum appeared to be a key molecule involved in the peripheral mechanism of MA-induced antinociception. The analgesic effect of MA or recombinant CXCL1 on inflammatory pain might be mediated through a peripheral opioid pathway, which needs further investigation.

Keywords

complete Freund’s adjuvant CXCL1 inflammatory pain manual acupuncture opioid

Get full access to this article

View all access options for this article.

References

Taneja

Della Pasqua

Danhof

Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Eur J Clin Pharmacol 2017; 73(10): 1219–1236.

Yin

Buchheit

Park

JJ.

Acupuncture for chronic pain: an update and critical overview. Curr Opin Anaesthesiol 2017; 30(5): 583–592.

Chang

Hsu

, et al. The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: a systemic review and meta-analysis. Neurourol Urodyn 2017; 36: 474–481.

Hong

Zhao

, et al. Acupuncture alleviates rheumatoid arthritis by immune-network modulation. Am J Chin Med 2018; 46(5): 997–1019.

Cook

Christensen

Tewari

, et al. Immune cytokines and their receptors in inflammatory pain. Trends Immunol 2018; 39(3): 240–255.

White

Wilson

NM.

Chemokines as pain mediators and modulators. Curr Opin Anaesthesiol 2008; 21(5): 580–585.

Silva

Lopes

GuimarÃ£es

, et al. CXCL1/CXCR2 signaling in pathological pain: role in peripheral and central sensitization. Neurobiol Dis 2017; 105: 109–116.

Wang

Gehringer

Mousa

, et al. CXCL10 controls inflammatory pain via opioid peptide-containing macrophages in electroacupuncture. PLoS ONE 2014; 9(4): e94696.

Da Silva

Bobinski

Sato

, et al. IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain. Mol Neurobiol 2015; 51(1): 19–31.

10.

Zhang

Cao

Zhang

, et al. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 2013; 154(10): 2185–2197.

11.

Sun

Sahbaie

Liang

, et al. Opioids enhance CXCL1 expression and function after incision in mice. J Pain 2014; 15(8): 856–866.

12.

Cao

Zhang

Xie

, et al. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol 2014; 261: 328–336.

13.

Brack

Rittner

Machelska

, et al. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 2004; 112(3): 229–238.

14.

Rittner

Machelska

Stein

Leukocytes in the regulation of pain and analgesia. J Leukoc Biol 2005; 78(6): 1215–1222.

15.

Hong

Ding

, et al. Strong manual acupuncture manipulation could better inhibit spike frequency of the dorsal horn neurons in rats with acute visceral nociception. Evid Based Complement Alternat Med 2015; 2015: 675437.

16.

Quinton

Nelson

Zhang

, et al. Effects of systemic and local CXC chemokine administration on the ethanol-induced suppression of pulmonary neutrophil recruitment. Alcohol Clin Exp Res 2005; 29(7): 1198–1205.

17.

Buschmann

Koch

Braach

, et al. CXCL1-triggered interaction of LFA1 and ICAM1 control glucose-induced leukocyte recruitment during inflammation in vivo. Mediators Inflamm 2012; 2012: 739176.

18.

Taguchi

Kitakoji

Involvement of peripheral opioid receptors in electroacupuncture analgesia for carrageenan-induced hyperalgesia. Brain Res 2010; 1355: 97–103.

19.

Zhang

Lao

Ren

, et al. Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology 2014; 120(2): 482–503.

20.

Luo

Zhang

Wang

, et al. Therapeutic effect of anti-CXCL1 neutralizing antibody on acute ulcerative colitis in mice. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2017; 42: 1375–1382.

21.

Manjavachi

Passos

Trevisan

, et al. Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology 2019; 151: 136–143.

22.

Zhou

, et al. Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway. Neuropharmacology 2018; 135: 34–47.

23.

Wang

, et al. Crosstalk between NFκB-dependent astrocytic CXCL1 and neuron CXCR2 plays a role in descending pain facilitation. J Neuroinflammation 2019; 16: 1.

24.

Machelska

Stein

Leukocyte-derived opioid peptides and inhibition of pain. J Neuroimmune Pharmacol 2006; 1(1): 90–97.

25.

Iwaszkiewicz

Schneider

Hua

Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol 2013; 4: 132.

26.

Cao

Malon

JT.

Anti-nociceptive role of CXCL1 in a murine model of peripheral nerve injury-induced neuropathic pain. Neuroscience 2018; 372: 225–236.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB